Bd announces fda 510(k) submission for bd alaris™ system

Franklin lakes, n.j., april 26, 2021 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, today announced it has submitted a 510(k) premarket notification to the u.s. food and drug administration (fda) for the bd alaris™ system, the most widely used infusion pump in acute care hospitals across the united states.
BDX Ratings Summary
BDX Quant Ranking